These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37667195)

  • 1. SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review.
    Jing X; Han M; Wang X; Zhou L
    BMC Infect Dis; 2023 Sep; 23(1):577. PubMed ID: 37667195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis.
    Alhumaid S; Al Mutair A; Al Alawi Z; Rabaan AA; Tirupathi R; Alomari MA; Alshakhes AS; Alshawi AM; Ahmed GY; Almusabeh HM; Alghareeb TT; Alghuwainem AA; Alsulaiman ZA; Alabdulmuhsin MA; AlBuwaidi EA; Dukhi AKB; Mufti HN; Al-Qahtani M; Dhama K; Al-Tawfiq JA; Al-Omari A
    Allergy Asthma Clin Immunol; 2021 Oct; 17(1):109. PubMed ID: 34656181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework.
    Kavikondala S; Haeussler K; Wang X; Bausch-Jurken MT; Nassim M; Mishra NK; Malmenäs M; Sharma P; Van de Velde N; Green N; Beck E
    Infect Dis Ther; 2024 Apr; 13(4):779-811. PubMed ID: 38498109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel.
    Maltezou HC; Gamaletsou MN; Giannouchos TV; Koukou DM; Karapanou A; Sourri F; Syrimi N; Lemonakis N; Peskelidou E; Papanastasiou K; Souliotis K; Lourida A; Panagopoulos P; Hatzigeorgiou D; Sipsas NV
    J Hosp Infect; 2023 Feb; 132():46-51. PubMed ID: 36473554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults.
    Xu K; Wang Z; Qin M; Gao Y; Luo N; Xie W; Zou Y; Wang J; Ma X
    Front Immunol; 2023; 14():1113156. PubMed ID: 36936964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis.
    Ssentongo P; Ssentongo AE; Voleti N; Groff D; Sun A; Ba DM; Nunez J; Parent LJ; Chinchilli VM; Paules CI
    BMC Infect Dis; 2022 May; 22(1):439. PubMed ID: 35525973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
    Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB
    Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection after COVID-19 vaccinations among vaccinated individuals, prevention rate of COVID-19 vaccination: A systematic review and meta-analysis.
    Dinagde DD; Degefa BD; Kitil GW; Feyisa GT; Marami SN
    Heliyon; 2024 May; 10(9):e30609. PubMed ID: 38737290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of SARS-CoV-2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta-analysis and meta-regression.
    Bhurwal A; Mutneja H; Bansal V; Goel A; Arora S; Attar B; Minacapelli CD; Kochhar G; Chen LA; Brant S; Seril D
    Aliment Pharmacol Ther; 2022 May; 55(10):1244-1264. PubMed ID: 35355306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis.
    Xu S; Li J; Wang H; Wang F; Yin Z; Wang Z
    BMC Med; 2023 Apr; 21(1):160. PubMed ID: 37106390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence of Irritable Bowel Syndrome after Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Their Association: A Systematic Review and Meta-Analysis of Observational Studies.
    Wang Z; Peng Y; Chen M; Peng L; Huang Y; Lin W
    J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of SARS-CoV-2 vaccines and the dose-response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials.
    Yang ZR; Jiang YW; Li FX; Liu D; Lin TF; Zhao ZY; Wei C; Jin QY; Li XM; Jia YX; Zhu FC; Yang ZY; Sha F; Feng ZJ; Tang JL
    Lancet Microbe; 2023 Apr; 4(4):e236-e246. PubMed ID: 36868258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.
    Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M
    JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the Cologne Corona Surveillance (CoCoS) project- a cross-sectional study: survey data on risk factors of SARS-CoV-2 infection, and moderate-to-severe course in primarily immunized adults.
    Oberste M; Asenova T; Ernst A; Shah-Hosseini K; Schnörch N; Buess M; Rosenberger KD; Kossow A; Dewald F; Neuhann F; Hellmich M
    BMC Public Health; 2024 Feb; 24(1):548. PubMed ID: 38383381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US.
    Sun J; Zheng Q; Madhira V; Olex AL; Anzalone AJ; Vinson A; Singh JA; French E; Abraham AG; Mathew J; Safdar N; Agarwal G; Fitzgerald KC; Singh N; Topaloglu U; Chute CG; Mannon RB; Kirk GD; Patel RC;
    JAMA Intern Med; 2022 Feb; 182(2):153-162. PubMed ID: 34962505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does potential antibody-dependent enhancement occur during SARS-CoV-2 infection after natural infection or vaccination? A meta-analysis.
    Gan L; Chen Y; Tan J; Wang X; Zhang D
    BMC Infect Dis; 2022 Sep; 22(1):742. PubMed ID: 36123623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis.
    Luo X; Lessomo FYN; Yu Z; Xie Y
    Front Immunol; 2023; 14():1145081. PubMed ID: 37731498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 Participants.
    DeSantis SM; Yaseen A; Hao T; León-Novelo L; Talebi Y; Valerio-Shewmaker MA; Pinzon Gomez CL; Messiah SE; Kohl HW; Kelder SH; Ross JA; Padilla LN; Silberman M; Tuzo S; Lakey D; Shuford JA; Pont SJ; Boerwinkle E; Swartz MD
    J Infect Dis; 2023 May; 227(10):1164-1172. PubMed ID: 36729177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
    Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.